Target intelligence / Profile preview

Biological membranes, viral envelopes, and protein structures

Molecular classification
Other, Lipid bilayer, Protein
01

Overview

The term Biological membranes, viral envelopes, and protein structures refers to a broad collection of fundamental biological assemblies rather than a single, specific therapeutic target. Biological membranes are semi-permeable lipid bilayers that define cellular boundaries and regulate molecular transport, while viral envelopes are host-derived lipid layers containing viral glycoproteins necessary for host cell attachment and entry (Alberts et al., Molecular Biology of the Cell, 2002; Harrison, Nature, 2008). Protein structures represent the complex three-dimensional arrangements of amino acids that determine the functional activity of enzymes, receptors, and structural components. In a pharmacological context, these structures are targeted by diverse agents; for example, polyene antifungals like Amphotericin B disrupt fungal membranes by binding to ergosterol, and fusion inhibitors like Enfuvirtide target viral envelope proteins to prevent infection (Baginski & Czub, Current Drug Targets, 2009; Lalezari et al., NEJM, 2003). Because this entry aggregates distinct physical entities—lipids and proteins—it is classified as a category of targets or a structural description rather than a discrete molecular target for drug development.

Other names
Cellular membranesViral lipid bilayersProtein architectureBiological barriersLipid envelopes
02

Mechanism of action

Disruption of lipid bilayer integrity, formation of transmembrane pores, inhibition of viral-host membrane fusion, or modulation of protein conformational stability.

03

Biological functions

Cellular compartmentalizationViral entry and fusionSignal transductionMolecular recognitionStructural integrity
04

Disease associations

InfectionCancerNeurodegenerative diseaseMetabolic disorders
05

Safety considerations

Systemic toxicity due to low specificityHemolysisNephrotoxicityOff-target disruption of host cell membranes
06

Interacting drugs

Amphotericin B

5 more in the full profile.

07

Biomarkers

Viral loadLactate dehydrogenase (LDH)Creatine kinaseC-reactive protein

Beyond the preview

Go deeper on Biological membranes, viral envelopes, and protein structures.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Biological membranes, viral envelopes, and protein structures.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call